SI2751115T1 - SPOJINE (TIENO(2,3-b)(1,5)BENZOKSAZEPIN-4-IL)PIPERAZIN-1-OLA KOT DVOJNO AKTIVNI H1 INVERZNI AGONISTI/5-HT2A ANTAGONISTI - Google Patents

SPOJINE (TIENO(2,3-b)(1,5)BENZOKSAZEPIN-4-IL)PIPERAZIN-1-OLA KOT DVOJNO AKTIVNI H1 INVERZNI AGONISTI/5-HT2A ANTAGONISTI

Info

Publication number
SI2751115T1
SI2751115T1 SI201231078T SI201231078T SI2751115T1 SI 2751115 T1 SI2751115 T1 SI 2751115T1 SI 201231078 T SI201231078 T SI 201231078T SI 201231078 T SI201231078 T SI 201231078T SI 2751115 T1 SI2751115 T1 SI 2751115T1
Authority
SI
Slovenia
Prior art keywords
benzoxazepin
thieno
piperazin
compounds
inverse agonists
Prior art date
Application number
SI201231078T
Other languages
English (en)
Inventor
Andrew James Ledgard
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI2751115T1 publication Critical patent/SI2751115T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI201231078T 2011-08-30 2012-08-22 SPOJINE (TIENO(2,3-b)(1,5)BENZOKSAZEPIN-4-IL)PIPERAZIN-1-OLA KOT DVOJNO AKTIVNI H1 INVERZNI AGONISTI/5-HT2A ANTAGONISTI SI2751115T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161528893P 2011-08-30 2011-08-30
EP12756856.6A EP2751115B1 (en) 2011-08-30 2012-08-22 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
PCT/US2012/051833 WO2013032804A1 (en) 2011-08-30 2012-08-22 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS

Publications (1)

Publication Number Publication Date
SI2751115T1 true SI2751115T1 (sl) 2017-11-30

Family

ID=46829875

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231078T SI2751115T1 (sl) 2011-08-30 2012-08-22 SPOJINE (TIENO(2,3-b)(1,5)BENZOKSAZEPIN-4-IL)PIPERAZIN-1-OLA KOT DVOJNO AKTIVNI H1 INVERZNI AGONISTI/5-HT2A ANTAGONISTI

Country Status (22)

Country Link
US (1) US9512140B2 (sl)
EP (1) EP2751115B1 (sl)
JP (1) JP6042436B2 (sl)
KR (1) KR101596607B1 (sl)
CN (1) CN103958523B (sl)
AU (1) AU2012300451B2 (sl)
BR (1) BR112014004557A2 (sl)
CA (1) CA2843514C (sl)
DK (1) DK2751115T3 (sl)
EA (1) EA024248B1 (sl)
ES (1) ES2650225T3 (sl)
HR (1) HRP20171824T1 (sl)
HU (1) HUE034845T2 (sl)
LT (1) LT2751115T (sl)
MX (1) MX350419B (sl)
NO (1) NO2776955T3 (sl)
PL (1) PL2751115T3 (sl)
PT (1) PT2751115T (sl)
RS (1) RS56537B1 (sl)
SI (1) SI2751115T1 (sl)
WO (1) WO2013032804A1 (sl)
ZA (1) ZA201400874B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2729474T (pt) * 2011-07-08 2018-06-05 Lilly Co Eli Compostos (tieno[2,3-b][1,5]benzoxazepin-4-il)piperazin-1-ilo tendo actividade dual como agonistas inversos de h1/antagonistas de 5-ht2a
EA026328B1 (ru) 2013-01-14 2017-03-31 Эли Лилли Энд Компани (ТИЕНО[2,3-b][1,5]БЕНЗОКСАЗЕПИН-4-ИЛ)ПИПЕРАЗИН-1-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ АГЕНТОВ С ДВОЙНОЙ АКТИВНОСТЬЮ: ОБРАТНЫХ АГОНИСТОВ Н1/АНТАГОНИСТОВ 5-НТ
TW201625644A (zh) 2014-04-29 2016-07-16 美國禮來大藥廠 作為選擇性５－ＨＴＡ反向促效劑之（噻吩并［２，３－ｂ］［１，５］苯并氧氮呯－４－基）哌嗪－１－基化合物
WO2018177993A1 (de) 2017-03-31 2018-10-04 Bayer Cropscience Aktiengesellschaft Pyrazole zur bekämpfung von arthropoden
WO2018234488A1 (en) 2017-06-23 2018-12-27 Basf Se SUBSTITUTED CYCLOPROPYL DERIVATIVES
WO2019185413A1 (en) 2018-03-27 2019-10-03 Basf Se Pesticidal substituted cyclopropyl derivatives
KR20210106528A (ko) * 2018-12-21 2021-08-30 오게다 에스.에이. 3-메틸-1,2,4-티아디아졸-5-카보하이드라지드 또는 이의 메틸-d3 중수소화 형태의 합성
EP4043444A1 (en) 2021-02-11 2022-08-17 Basf Se Substituted isoxazoline derivatives
EP4291551A1 (en) 2021-02-11 2023-12-20 Basf Se Substituted isoxazoline derivatives
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7395251B2 (en) * 2005-07-01 2008-07-01 International Business Machines Corporation Neural networks for prediction and control
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof

Also Published As

Publication number Publication date
NO2776955T3 (sl) 2018-06-02
HRP20171824T1 (hr) 2017-12-29
MX2014002473A (es) 2016-09-26
US20140171411A1 (en) 2014-06-19
ZA201400874B (en) 2015-10-28
US9512140B2 (en) 2016-12-06
MX350419B (es) 2017-09-05
HUE034845T2 (en) 2018-03-28
CA2843514A1 (en) 2013-03-07
AU2012300451B2 (en) 2016-10-13
KR20140051355A (ko) 2014-04-30
LT2751115T (lt) 2017-12-27
DK2751115T3 (en) 2017-10-23
ES2650225T3 (es) 2018-01-17
PT2751115T (pt) 2017-12-20
CN103958523B (zh) 2016-07-27
EP2751115B1 (en) 2017-09-20
WO2013032804A1 (en) 2013-03-07
EP2751115A1 (en) 2014-07-09
CA2843514C (en) 2017-01-10
CN103958523A (zh) 2014-07-30
PL2751115T3 (pl) 2018-02-28
RS56537B1 (sr) 2018-02-28
EA201490332A1 (ru) 2014-06-30
JP2014525440A (ja) 2014-09-29
JP6042436B2 (ja) 2016-12-14
BR112014004557A2 (pt) 2017-05-30
AU2012300451A1 (en) 2014-01-30
EA024248B1 (ru) 2016-08-31
KR101596607B1 (ko) 2016-02-22

Similar Documents

Publication Publication Date Title
HRP20171724T1 (hr) Imidazo[1,2-b]piridazin derivati kao inhibitori kinaze
SI2751115T1 (sl) SPOJINE (TIENO(2,3-b)(1,5)BENZOKSAZEPIN-4-IL)PIPERAZIN-1-OLA KOT DVOJNO AKTIVNI H1 INVERZNI AGONISTI/5-HT2A ANTAGONISTI
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
IL227496B (en) Pyrazolo[4,3–b]pyridines are converted as drugs
SI2776442T1 (sl) Derivati (1,2,3)triazolo(4,5-d)pirimidina kot agonisti kanabinoidnega receptorja 2
IL232304A0 (en) [1,2,3]-Triazolo[4,5-d]pyrimidine derivatives are agonistic for cannabinoid receptor 2 agonists
HRP20180475T1 (hr) (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI, DVOJNO AKTIVNI KAO INVERZNI AGONISTI H1/ANTAGONISTI 5-HT2A
HRP20150469T1 (hr) SUPSTITUIRANI SPOJEVI [(5H-PIROLO[2,1-c][1,4]BENZODIAZEPIN-11-IL)PIPERAZIN-1-IL]-2,2-DIMETILPROPANSKE KISELINE KAO DVOSTRUKO DJELUJUĆI INVERZNI AGONISTI H1/ANTAGONISTI HT2A
EP2882748A4 (en) 5- (1H-PYRAZOL-4-YL-) 1H-PYRROLO- [2,3-B-] PYRIDINE DERIVATIVES AS A KINASE INHIBITOR
ZA201504041B (en) (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists